Clinical trials recruiting for Pulmonary hypertension
95
Recruiting trials
42
US states with sites
36
Countries
20%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 11 |
| Pennsylvania | 11 |
| Florida | 10 |
| Minnesota | 9 |
| California | 8 |
| Colorado | 8 |
| New York | 8 |
| North Carolina | 8 |
| South Carolina | 8 |
| Kansas | 7 |
| Kentucky | 7 |
| Michigan | 7 |
Top cities
Cincinnati, Ohio 9Philadelphia, Pennsylvania 9Kansas City, Kansas 7New York, New York 7Rochester, Minnesota 7Boston, Massachusetts 6Charleston, South Carolina 6Houston, Texas 6Indianapolis, Indiana 6Louisville, Kentucky 6
Self-screener
Recruiting trials
- 129 Xenon Imaging in Patients Treated With Sotatercept
- A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
- A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
- Accuracy of Smartwatches in Measuring Oxygen Levels in Patients With Pulmonary Hypertension: A Pilot Study
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Antiphospholipid Syndrome and Postpartum Pulmonary Artery Pressure
- Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension
- Association Between Biomarkers and Kidney Function Decline in Pulmonary Hypertension
- Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Bioenergetic Effect of Pioglitazone in CLD-PH
- Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
- Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
- CHASE Registry of Patients With Pulmonary Hypertension Receiving Targeted Therapy
- CVD/PH and Voice Characteristics
- Cardiovascular Risk in Children With Chronic Conditions Study
- China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization
- Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease
- Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients
- Controlled Remote Monitoring and Optimization of Oxygen Therapy in Preterm Infants
- Database for Clinical and Anamnestic Data in Pulmonary Hypertension
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography
- Development of Novel Physiological CMR Methods in Health and Disease
- Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope
- Diaphragmatic Function as a Biomarker
- Digital Assessment of Real-World Walking Activity in Pulmonary Hypertension: A Prospective Multicenter Trial
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Electrical Impedance Tomography for Assessment of Pulmonary Hypertension
- Evaluation of Feasibility of Ultrasonography Guided Pulmonary Artery Catheterization in Pulmonary Hypertension Diagnosis
- Feasibility Trial for a Right Ventricular Failure Platform Trial
- Feasibility of Novel Clinical Trial Infrastructure, Design and Technology for Early Phase Studies in Patients With Pulmonary Hypertension (FIT-PH)
- Feasibility of Semaglutide in Advanced Lung Disease
- Feto-Endoscopic Tracheal Occlusion (FETO) for Severe Congenital Diaphragmatic Hernia
- Giessen Pulmonary Hypertension Registry and Biobank
- HS235 Study in Obese Participants With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction (HFpEF)
- Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
- Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
- Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
- Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension
- Insights Into Pediatric Pulmonary Hypertension: A Real-World Registry of Epidemiology and Outcomes
- Institutional Registry of Rare Diseases
- Interoceptive Intervention for Pulmonary Hypertension
- Mechanisms of Pulmonary Vascular Dysfunction in Heart Failure
- Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension
- MedlyPeds Feasibility Study
- Mobile Internet-based Remote Home Rehabilitation Improves Prognostic Function and Life Quality in Pulmonary Hypertension
- Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Multicenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic Sclerosis
- Multimodality RV Phenotyping for Risk Stratification and Short-Term Outcomes in Group 1 PAH
- Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
- NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot
- New Orleans Pulmonary Hypertension Biobank
- Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
- PET/MR Pre- and Post Radiotherapy for Cardiopulmonary Dysfunction Evaluation
- PH-DyPred: A Multimodal Dynamic Risk Prediction Study in Pulmonary Hypertension
- PVRI GoDeep Global Deep Phenotyping Meta-Registry for Pulmonary Hypertension
- Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Hypertension After Transcatheter Mitral Valve Edge-to-Edge Repair (M-TEER): A Prospective Cohort Study
- Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease
- Postcapillary Blood Gas Analysis in Wedge Position (Wedge-BGA)
- Preliminary Human Trials of F230 Tablets
- Prevalence, Pathogenesis, and Prognosis of Pulmonary Hypertension in Dialysis Patients
- Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension
- Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension
- Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study)
- Pulmonary Hypertension Association Registry
- Pulmonary Hypertension Biorepository and Registry
- Pulmonary Hypertension Observational Study
- Pulmonary Hypertension Registry Switzerland
- Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
- Pulmonary Hypertension in Left Heart Disease
- Real World Observational Study of Sotatercept for Pulmonary Hypertension
- Real-World Study of PADN for the Treatment of PAH
- Registration Study for Rare Type of Pulmonary Hypertension
- Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease
- Risk Factor Assessment for Acute Pulmonary Hypertension Crisis
- Rutgers University Study of the Genetics of Pulmonary Hypertension
- Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study
- Safety and Efficacy of FETO in CDH Phase III
- Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
- Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT)
- Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
- Study on the Treatment of Nonthrombotic Obstructive Pulmonary Hypertension
- Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease
- The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease
- The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
- Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass
- Validation of a Patient Knowledge Questionnaire for Pulmonary Hypertension
- Xenon MRI Pulm Hypertension
- iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
- the Application of Cardiopulmonary Exercise Testing in Assessment Outcome of Patients With Pulmonary Hypertension
Related conditions
Trials recruiting for Pulmonary hypertension often also study these conditions. Each links to its own recruiting-trial list.
Hypertension 1201Heart failure 1021Pulmonary arterial hypertension 49Interstitial Lung Disease 31COPD 444Cardiovascular Diseases 164Vascular Diseases 18Obesity 1512Fibrosis 7Congenital Diaphragmatic Hernia 6
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pulmonary hypertension trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.